European Crohn´s and Colitis Organisation - ECCO - The Council of National Representatives
Editorial_Board | Journal of Crohn's and Colitis | Oxford Academic
PDF) P621 Real-world effectiveness and safety of vedolizumab and anti-TNF in biologic-naive Crohn's disease patients: results from the EVOLVE study
Orally Administered Platinum Nanomarkers for Urinary Monitoring of Inflammatory Bowel Disease | ACS Nano
Editorial_Board | Journal of Crohn's and Colitis | Oxford Academic
Editorial_Board | Journal of Crohn's and Colitis | Oxford Academic
iBDNEWS#1/14
European Crohn´s and Colitis Organisation - ECCO - Uncategorised
ECCO in Vienna was the Best Congress Ever!
European Crohn´s and Colitis Organisation - ECCO - The Council of National Representatives
Editorial_Board | Journal of Crohn's and Colitis | Oxford Academic
PDF) Oral azathioprine for steroid refractory severe ulcerative colitis | Gerassimos Mantzaris - Academia.edu
European Crohn´s and Colitis Organisation - ECCO - The Council of National Representatives
PDF) Budesonide is superior to mesalazine in maintaining disease remission for patients with steroid-dependent Crohn's disease | Gerassimos Mantzaris - Academia.edu
Clinical profiles of moderate and severe Crohn's disease patients and use of anti-tumor necrosis factor agents: Greek expert consensus guidelines. - Abstract - Europe PMC
WINTER
PDF) Prevalence and Characteristics of Extra-intestinal Manifestations in a Large Cohort of Greek Patients with Inflammatory Bowel Disease
Tibor HLAVATY | Senior gastroenterologist | MD, PhD, Assoc. Prof | Department of internal medicine V. | Research profile
A continued story of success: Feeding science, digesting knowledge
Editorial_Board | Journal of Crohn's and Colitis | Oxford Academic
Vedolizumab and Anti-Tumour Necrosis Factor α Real-World Outcomes in Biologic-Naïve Inflammatory Bowel Disease Patients: Resul
Untitled
